A single-arm, phase II study of envafolimab combined with chemoradiotherapy and recombinant human endostatin in high-risk locally advanced nasopharyngeal carcinoma

被引：0
|
作者：
Zhang, H. [1 ]
Zhang, X. [2 ]
Wang, F. [2 ]
Sui, J. [2 ]
Wang, Y. [2 ]
机构：
[1] Chongqing Univ, Sch Med, Chongqing, Peoples R China
[2] Chongqing Univ, Canc Hosp, Radiat Oncol Ctr, Chongqing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.482
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
459TiP
引用
收藏
页数：2
相关论文
共 50 条
  • [41] NEOADJUVANT TORIPALIMAB COMBINED WITH AXITINIB IN PATIENTS WITH LOCALLY ADVANCED CLEAR CELL RENAL CELL CARCINOMA: A SINGLE-ARM, PHASE II TRIAL
    Huang, Jiwei
    JOURNAL OF UROLOGY, 2024, 211 (05): : E712 - E713
  • [42] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Yang, Guozhen
    Su, Xiaodong
    Huang, Yuanheng
    Luo, Guangyu
    Wang, Zhiqiang
    Cai, Peiqiang
    Zheng, Yating
    Bei, Ting
    Huang, Mengli
    Bai, Yuezong
    He, Haoqiang
    Xiang, Jin
    Cai, Muyan
    Zhong, Jiudi
    Guo, Qiyu
    Zhang, Xu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [43] Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial
    Huang, Jiwei
    Wang, Yueming
    Xu, Fan
    Wang, Zaoyu
    Wu, Guangyu
    Kong, Wen
    Cheoklong, Ng
    Tricard, Thibault
    Wu, Xiaorong
    Zhai, Wei
    Zhang, Wei
    Zhang, Jiyang
    Zhang, Ding
    Chen, Shuyin
    Lian, Yuqing
    Chen, Yonghui
    Zhang, Jin
    Huang, Yiran
    Xue, Wei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (06)
  • [44] Interim result of phase II, prospective, single-arm trial of long-course chemoradiotherapy combined with concurrent tislelizumab in locally advanced rectal cancer
    Gao, Jiale
    Zhang, Xiao
    Yang, Zhengyang
    Zhang, Jie
    Bai, Zhigang
    Deng, Wei
    Chen, Guangyong
    Xu, Rui
    Wei, Qi
    Liu, Yishan
    Han, Jiagang
    Li, Ang
    Liu, Gang
    Sun, Yi
    Kong, Dalu
    Yao, Hongwei
    Zhang, Zhongtao
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [45] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Guozhen Yang
    Xiaodong Su
    Yuanheng Huang
    Guangyu Luo
    Zhiqiang Wang
    Peiqiang Cai
    Yating Zheng
    Ting Bei
    Mengli Huang
    Yuezong Bai
    Haoqiang He
    Jin Xiang
    Muyan Cai
    Jiudi Zhong
    Qiyu Guo
    Xu Zhang
    Journal of Translational Medicine, 21
  • [46] Efficacy and safety of the combination of envafolimab and lenvatinib in unresectable hepatocellular carcinoma: a single-arm, multicentre, exploratory phase II clinical study
    Jiang, Yi
    Su, Ke
    Li, Han
    Wang, Chenjie
    Wu, Zhenying
    Chen, Jiali
    Zhang, Zhiyao
    He, Kun
    Han, Yunwei
    INVESTIGATIONAL NEW DRUGS, 2025, 43 (01) : 18 - 29
  • [47] Tislelizumab plus chemotherapy as induction treatment followed by chemoradiotherapy or surgery in locally advanced hypopharyngeal squamous cell carcinoma: A single-arm, phase II trial
    Gui, Lin
    Liu, Shaoyan
    Wang, Xiaolei
    Zhang, Ye
    He, Xiaohui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma (RICE): A Prospective, Single-Arm, Phase II Trial
    Lin, L.
    Li, H.
    Zhao, L.
    Cheng, Y.
    Liu, M. N.
    Fu, X.
    Liu, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E464 - E465
  • [49] Phase II study of induction chemotherapy followed by concurrent chemoradiotherapy with raltitrexed and cisplatin in locally advanced nasopharyngeal carcinoma
    Wu, Yuan
    Wei, Xueyan
    Yuan, Zilong
    Xu, Hongbin
    Li, Yanping
    Li, Ying
    Hu, Liu
    Han, Guang
    Qian, Yu
    Hu, Desheng
    CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (05) : 665 - 672
  • [50] Single institution phase II study of chemoradiotherapy with capecitabine in locally advanced rectal carcinoma.
    Moleron, R.
    Fernandez-Lizarbe, E.
    Veiras, M.
    Hernando, O.
    Garcia-Berrocal, M. I.
    De la Torre, A.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81
12345